CETP and type 2 diabetes mellitus: In the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial, treatment with the CETP inhibitor, torcetrapib, improved glycaemic control in statin-treated patients with T2D [12].